Skip to main content

Table 4 Observed vs. Predicted EQ-5D Utility by symptom group from QLQ-C30 + MY20 model

From: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma

  Actual Predicted (95% CI) Difference
Symptom group    
  Asymptomatic 0.923 0.893 (0.819; 0.967) 0.030
  Mildly symptomatic 0.806 0.833 (0.783; 0.883) −0.027
  Moderately symptomatic 0.675 0.679 (0.616; 0.743) −0.004
  Severely symptomatic 0.501 0.474 (0.398; 0.551) 0.027